Cost-effectiveness of once daily GLP-1 receptor agonist lixisenatide compared to bolus insulin both in combination with basal insulin for the treatment of patients with type 2 diabetes in Norway
These medications work by mimicking the bodys natural GLP-1 hormone, which reduces appetite, increases satiety, slows gastric emptying, and improves insulin regulation
Ethics statement Ethical approval was not required for this single case report in accordance with local institutional guidelines
With zero sugar and fast-absorbing liquid delivery, this formula provides clean, stimulant-free support for fat metabolism, thermogenic activity, and sustained energy
But its very interesting to learn about the kinds of breakthroughs that may be around the corner, she adds
N.KiefferT